A fresh round of sideways trading continues for Syndax Pharmaceuticals Inc (SNDX) Stock.
Scotiabank lowered the price target for the Syndax Pharmaceuticals Inc (NASDAQ:SNDX) stock from “a Sector outperform” to “a Sector perform”. The rating was released on January 31, 2024, according to finviz. The research report from BofA Securities has initiated the stock to Buy, with a price target set at $29. The stock was initiated by […]
Syndax Pharmaceuticals Inc (SNDX) Stock offers help to cash-strapped investors
Scotiabank lowered the price target for the Syndax Pharmaceuticals Inc (NASDAQ:SNDX) stock from “a Sector outperform” to “a Sector perform”. The rating was released on January 31, 2024, according to finviz. The research report from BofA Securities has initiated the stock to Buy, with a price target set at $29. The stock was initiated by […]
The market value of Syndax Pharmaceuticals Inc (SNDX) Stock is expected to soar in the coming months
Scotiabank lowered the price target for the Syndax Pharmaceuticals Inc (NASDAQ:SNDX) stock from “a Sector outperform” to “a Sector perform”. The rating was released on January 31, 2024, according to finviz. The research report from BofA Securities has initiated the stock to Buy, with a price target set at $29. The stock was initiated by […]
Syndax Pharmaceuticals Inc (NASDAQ:SNDX) stock Market Value Reached at $1.94 billion: What Happened?
Scotiabank lowered the price target for the Syndax Pharmaceuticals Inc (NASDAQ:SNDX) stock from “a Sector outperform” to “a Sector perform”. The rating was released on January 31, 2024, according to finviz. The research report from BofA Securities has initiated the stock to Buy, with a price target set at $29. The stock was initiated by […]
The Underside Of Syndax Pharmaceuticals Inc (SNDX) Stock Is A Little Uncertain
Scotiabank lowered the price target for the Syndax Pharmaceuticals Inc (NASDAQ:SNDX) stock from “a Sector outperform” to “a Sector perform”. The rating was released on January 31, 2024, according to finviz. The research report from BofA Securities has initiated the stock to Buy, with a price target set at $29. The stock was initiated by […]
Syndax Pharmaceuticals Inc (SNDX) Stock is looking to regain its victory
Scotiabank lowered the price target for the Syndax Pharmaceuticals Inc (NASDAQ:SNDX) stock from “a Sector outperform” to “a Sector perform”. The rating was released on January 31, 2024, according to finviz. The research report from BofA Securities has initiated the stock to Buy, with a price target set at $29. The stock was initiated by […]
Syndax Pharmaceuticals Inc (NASDAQ:SNDX) Stock Price Slipped -1.31% to $22.58
Scotiabank lowered the price target for the Syndax Pharmaceuticals Inc (NASDAQ:SNDX) stock from “a Sector outperform” to “a Sector perform”. The rating was released on January 31, 2024, according to finviz. The research report from BofA Securities has initiated the stock to Buy, with a price target set at $29. The stock was initiated by […]
Is Syndax Pharmaceuticals Inc (SNDX) Stock Paving the Way for Earnings?
Scotiabank lowered the price target for the Syndax Pharmaceuticals Inc (NASDAQ:SNDX) stock from “a Sector outperform” to “a Sector perform”. The rating was released on January 31, 2024, according to finviz. The research report from BofA Securities has initiated the stock to Buy, with a price target set at $29. The stock was initiated by […]
A Tale from the Dusty Corner: Syndax Pharmaceuticals Inc (SNDX) Stock
Scotiabank lowered the price target for the Syndax Pharmaceuticals Inc (NASDAQ:SNDX) stock from “a Sector outperform” to “a Sector perform”. The rating was released on January 31, 2024, according to finviz. The research report from BofA Securities has initiated the stock to Buy, with a price target set at $29. The stock was initiated by […]